Detalhe da pesquisa
1.
Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience?
Qual Life Res
; 32(9): 2587-2599, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37097405
2.
Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018.
BMC Pulm Med
; 23(1): 16, 2023 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36639770
3.
Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe.
BMC Cancer
; 22(1): 693, 2022 Jun 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35739480
4.
Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis.
BMC Cancer
; 22(1): 255, 2022 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35264135
5.
Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF study.
Future Oncol
; 18(2): 205-214, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34784783
6.
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
Future Oncol
; 17(19): 2439-2448, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33769073
7.
Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative.
Eur J Cancer Care (Engl)
; 30(6): e13496, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34288191
8.
Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from the I-O Optimise Initiative.
Cancers (Basel)
; 16(9)2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38730607
9.
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Transl Lung Cancer Res
; 12(10): 2113-2128, 2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38025806
10.
The Predictive and Prognostic Nature of Programmed Death-Ligand 1 in Malignant Pleural Mesothelioma: A Systematic Literature Review.
JTO Clin Res Rep
; 3(5): 100315, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35516726
11.
Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany.
Lung Cancer
; 172: 65-74, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36007281
12.
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts.
Cancers (Basel)
; 14(24)2022 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36551632
13.
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.
Lung Cancer
; 167: 8-16, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35367910
14.
Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Lung Cancer
; 162: 185-193, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34823894
15.
Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.
BMJ Open
; 11(9): e046396, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34526333
16.
Epidemiology and Survival Outcomes for Patients With NSCLC in Scandinavia in the Preimmunotherapy Era: A SCAN-LEAF Retrospective Analysis From the I-O Optimise Initiative.
JTO Clin Res Rep
; 2(5): 100165, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34590017